NextCure, Inc. (NXTC) DCF Valuation

NextCure, Inc. (NXTC) DCF Valuation

US | Healthcare | Biotechnology | NASDAQ
NextCure, Inc. (NXTC) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

NextCure, Inc. (NXTC) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate NextCure, Inc.'s (NXTC) financial outlook like an expert! This (NXTC) DCF Calculator comes with pre-filled financial data and offers complete flexibility to modify revenue growth, WACC, margins, and other essential assumptions according to your projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 6.3 22.4 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 252.58 -100 0 0 0 0 0 0 0
EBITDA -34.8 -37.8 -65.0 -70.3 -59.0 .0 .0 .0 .0 .0
EBITDA, % -548.2 -168.97 100 100 100 20 20 20 20 20
Depreciation 2.7 3.4 4.3 4.5 3.7 .0 .0 .0 .0 .0
Depreciation, % 42.35 15.25 100 100 100 71.52 71.52 71.52 71.52 71.52
EBIT -37.5 -41.2 -69.3 -74.7 -62.7 .0 .0 .0 .0 .0
EBIT, % -590.55 -184.22 100 100 100 20 20 20 20 20
Total Cash 334.6 283.4 219.6 159.9 108.3 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 0 0 100 100 100
Inventories .0 .0 .0 -.7 .0 .0 .0 .0 .0 .0
Inventories, % 0 0 100 100 100 60 60 60 60 60
Accounts Payable 1.9 3.9 1.9 4.3 2.3 .0 .0 .0 .0 .0
Accounts Payable, % 29.32 17.43 100 100 100 69.35 69.35 69.35 69.35 69.35
Capital Expenditure -3.4 -7.1 -2.4 -2.1 -.8 .0 .0 .0 .0 .0
Capital Expenditure, % -53.11 -31.87 100 100 100 -17 -17 -17 -17 -17
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -37.5 -37.4 -69.3 -69.4 -62.7 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -36.3 -39.1 -69.3 -64.0 -62.5 -2.3 .0 .0 .0 .0
WACC, % 7.35 7.25 7.35 7.27 7.35 7.31 7.31 7.31 7.31 7.31
PV UFCF
SUM PV UFCF -2.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt -6
Equity Value 4
Diluted Shares Outstanding, MM 28
Equity Value Per Share 0.15

What You Will Get

  • Real NextCure Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on NextCure’s fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections.
  • Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility.

Key Features

  • Pre-Loaded Data: NextCure, Inc.'s historical financial statements and pre-filled forecasts.
  • Fully Adjustable Inputs: Edit WACC, tax rates, revenue growth, and EBITDA margins.
  • Instant Results: See NextCure, Inc.'s intrinsic value recalculate in real time.
  • Clear Visual Outputs: Dashboard charts display valuation results and key metrics.
  • Built for Accuracy: A professional tool for analysts, investors, and finance experts.

How It Works

  • Download: Obtain the pre-built Excel file containing NextCure, Inc.'s (NXTC) financial data.
  • Customize: Modify projections, including revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various projections and instantly compare results.
  • Make Decisions: Leverage the valuation findings to inform your investment strategy.

Why Choose This Calculator?

  • Accurate Data: Real NextCure, Inc. (NXTC) financials ensure reliable valuation results.
  • Customizable: Adjust key parameters like growth rates, WACC, and tax rates to match your projections.
  • Time-Saving: Pre-built calculations eliminate the need to start from scratch.
  • Professional-Grade Tool: Designed for investors, analysts, and consultants.
  • User-Friendly: Intuitive layout and step-by-step instructions make it easy for all users.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and accurate valuation models for analyzing NextCure, Inc. (NXTC) within their portfolios.
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions regarding NextCure, Inc. (NXTC).
  • Consultants and Advisors: Deliver precise valuation insights for clients interested in NextCure, Inc. (NXTC) stock.
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling with a focus on NextCure, Inc. (NXTC).
  • Biotech Enthusiasts: Gain insights into how biotech firms like NextCure, Inc. (NXTC) are valued in the investment landscape.

What the Template Contains

  • Preloaded NXTC Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.